fbpx

SWISS PHARMACAN'S SUPPLEMENT AUTHORIZED FOR IMMEDIATE CLINICAL STUDY TO CONFIRM EFFECTIVENESS AGAINST LONG-COVID

"The use of ArtemiC Support has shown clear improvement of Long-COVID symptoms after just a few days", states research collaborator Dr. Francisco Mera Cordero from the Catalan Health Authority DAP Costa de Ponent.
COVID-19 is mainly a respiratory disease with possible long-term effects on other organs [1] . Even after recovery from the acute phase, about 40% [2] of adult COVID-19 patients develop long-term COVID symptoms. Studies show that 70% of patients have damage in at least one organ [3] . “These patients are severely debilitated and can suffer from neurological symptoms – paresthesia, dysesthesia, pins and needles in the face, arms or legs, lack of energy, a lot of fatigue and even breathing problems,” Mera Cordero continues.

HOPE FOR LONG COVID PATIENTS

10 to 20 percent of all Covid-19 patients develop Long Covid and continue to suffer for months after the acute phase. A unique supplement may help to prevent the long-term damage caused by this virus.
On 13 January 2020, Jan Kling called the office to let them know he would not be coming to work today. The 60-year-old Dutchman, physically fit and without any previous illnesses, had never had flu in his life, only a cold once in a while. But that day, everything was different. “I felt really sick. I was coughing almost non-stop. I didn't have a fever, but I suffered from extreme headaches, ”describes Kling. Home remedies for the cough and paracetamol for the headache did not help. After five days, he finally went to the doctor. They suspected he had the flu and advised him to simply wait out the illness.

Roby Zomer

Co-founder and Managing Director
at MGC Pharma
"This study is a crucial first step in determining whether ArtemiC Support® help long COVID sufferers treat what is often a very debilitating condition."

Dr. Francisco Mera Cordero

The Catalan Health Authority DAP
Costa de Ponent
"The use of ArtemiC Support has shown clear improvement of Long-COVID symptoms after just a few days."

Dr. Martin Edlinger

Specialist for General Medicine (FMH)
at Clinica Austria in Alicante
“In our practice, we had 33 Long Covid patients. All of them were symptoms-free after just 14 days of ArtemiC. "

Dr. Nadya Lisovoder

CEO, Galilee Clinical Bio Research
“ArtemiC was able to reduce the inflammation of cell tissue and prevent the incubated production of the cytokines that cause that uncontrolled inflammation. In the pre-clinical in-vitro trials, we took tissue that had been induced to produce cytokines and added a controlled dose of ArtemiC anti-inflammatory agent. What we found is that ArtemiC is capable of actually stopping the production of new cytokines. "  

POWERED BY MYCELL TECHNOLOGY

After 15 years of extensive research, the scientists of MyCell ™ Technology have achieved our goal to transform nutraceuticals into pure bioavailability. We are proud to say that we have succeeded in imitating what our body does naturally, and we've done it by taking all-natural ingredients and making them more efficient. We've solved the issues that have long plagued nutraceuticals, including protection, stability, solubility, improved intestinal permeability, cellular targeting and extended half-life.

PROVEN RESULTS

Making fat compounds soluble in water is just one of the benefits of MyCell ™ Technology. Our revolutionary method of creating nutraceuticals in a water-soluble form has proven results.  
Compounds are protected and more stable and the dissolution rate is enhanced. MyCell ™ Technology introduces extended circulation, improved intestinal permeability and optimal cellular uptake. Put together, these improvements boost bioavailability to almost 100%. Our MyCell ™ -enhanced ingredients deliver natural products with fast and noticeable desired results.

Download the MyCell Technology Fact Sheet


Get unique insights into trial results and learn how the award-winning MyCell ™ Technology optimizes the absorption of nutraceuticals.
We guarantee that your data will never be shared with any third party. We will only contact you with important updates on our products and technology.

GET IN TOUCH WITH US

Robert Leidelmeijer

Marketing & Communication

Eric Janssen

Business development

Adrian Fuchs

ArtemiC specialist

BE THE FIRST TO KNOW THE RESULTS OF CLINICAL STUDY

Swiss Pharmacan logo

Swiss PharmaCan AG

  • Zürcherstrasse 310
    8500 Frauenfeld
    Switzerland


© Swiss Pharmacan AG. All rights reserved.